Drugs / TTK-567
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00669292 | Nov 2006 → Nov 2009 | esophageal cancer | Wakayama Medical University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TTK-567 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00669292 ↗ |
| Modality | Peptide | “TTK-567 peptide(1mg)” NCT00669292 ↗ |
| Route | Subcutaneous | “will be administered by subcutaneous injection” NCT00669292 ↗ |